61
3
4
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T11027 | DHODH-IN-4 | Dehydrogenase | |
DHODH-IN-4 is a human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) inhibitor. The IC50 values of PfDHODH and HsDHODH are 4 μM and 0.18 μM, respectively. DHODH-IN-4 has antimalarial activity. | |||
T11019 | DHODH-IN-1 | Dehydrogenase | |
DHODH-IN-1 is a potent dihydroorotate dehydrogenase (DHODH) inhibitor with IC50 of 25 nM. DHODH-IN-1 is an inhibitor of the pyrimidine biosynthetic pathway. | |||
T11023 | DHODH-IN-14 | Dehydrogenase | |
DHODH-IN-14 is an analog of hydroxyfuran pyrimidine A771726. DHODH-IN-14 is a dihydroorotate dehydrogenase (DHODH) inhibitor IC50 0.49 μM mouse liver DHODH. DHODH-IN-14 can be used for rheumatoid arthritis. | |||
T11022 | DHODH-IN-13 | Dehydrogenase | |
DHODH-IN-13 is an inhibitor of DHODH with IC50 of 4.3 μM for rat liver. DHODH-IN-13 can be used in studies about rheumatoid arthritis. | |||
T40168 | DHODH-IN-16 | Dehydrogenase | |
DHODH-IN-16 is an effective inhibitor of dihydroorotate dehydrogenase (DHODH, IC50 = 0.396 nM for human). | |||
T11030 | DHODH-IN-8 | Dehydrogenase | |
DHODH-IN-8 has antimalarial activity. DHODH-IN-8 is an inhibitor of human and Plasmodium falciparum dihydroorotate dehydrogenase (DHODH) with IC50 of 0.13 μM and 47.4 μM, and Kis of 0.016 μM and 5.6 μM, respectively. | |||
T11024 | DHODH-IN-15 | Dehydrogenase | |
DHODH-IN-15 is the hydroxyfuran analogue of A771726. DHODH-IN-15 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 11 μM for rat liver DHODH. DHODH-IN-15 can be used for rheumatoid arthritis. | |||
T11021 | DHODH-IN-12 | Dehydrogenase | |
DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07. | |||
T11020 | DHODH-IN-11 | Dehydrogenase , DNA/RNA Synthesis | |
DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03. | |||
T67875 | DHODH-IN-23 | Dehydrogenase | |
DHODH-IN-23 is a DHODH inhibitor with oral activity. DHODH-IN-23 is often used in cancer research. | |||
T60364 | DHODH-IN-17 | Dehydrogenase | |
DHODH-IN-17 is a human DHODH inhibitor with an IC50 of 0.40 μM. DHODH-IN-17 is a 2- anilino nicotinic acid that can be used in the study of acute myeloid leukemia (AML). | |||
T11031 | HDHODH-IN-7 | DHODH-IN-9 | Dehydrogenase |
hDHODH-IN-7 (DHODH-IN-9) is a nitrogen-containing analog and is a human dihydrorotatory dehydrogenase inhibitor. hDHODH-IN-7 and pMIC50 of 7.4 have antiviral effects. | |||
T11028 | HDHODH-IN-4 | DHODH-IN-5 | Dehydrogenase |
hDHODH-IN-4 (DHODH-IN-5) is a potent inhibitor of human dihydrogen dehydrogenase (DHODH). For human recombinant DHODH, its pIC50 is 7.8. hDHODH-IN-4 inhibits measles virus replication with a pMIC50 of 8.8. | |||
T11025 | HDHODH-IN-3 | DHODH-IN-2 | Dehydrogenase |
hDHODH-IN-3 is an inhibitor of human dihydroorotate dehydrogenase with a pMIC50 value of 8.6. hDHODH-IN-3 can inhibit measles virus replication. | |||
T11029 | HDHODH-IN-5 | DHODH-IN-7 | Dehydrogenase |
hDHODH-IN-5 is an inhibitor of human dihydroorotate dehydrogenase (hDHODH, IC50 = 0.91 μM). | |||
T40309 | DHODH-IN-18 | ||
DHODH-IN-18 is a human DHODH inhibitor ( IC 50 = 0.2 nM). | |||
T11026 | DHODH-IN-3 | Others | |
DHODH-IN-3 is an effective inhibitor of human dihydroorotate dehydrogenase (HsDHODH) with IC50 value of 261 nM. DHODH-IN-3 binds to the ubiquinone binding cavity in DHODH with a Kiapp of 32 nM. DHODH-IN-3 has the potenti... | |||
T63148 | DHODH-IN-20 | ||
Dhodh-in-20 (Compound 133) is a potent inhibitor of DHODH. Among them, DHODH is an iron-containing flavin-dependent enzyme that is present in the inner membrane of human mitochondria. DHODH-IN-20 showed an inhibitory eff... | |||
T63617 | DHODH-IN-21 | ||
DHODH-IN-21 is an orally active, selective dihydrolactate dehydrogenase (DHODH) inhibitor (IC50: 1.1 nM). DHODH-IN-21 exhibits anticancer effects and can be used to study acute myeloid leukemia (AML). | |||
T63880 | DHODH-IN-22 | ||
DHODH-IN-22 is a potent, selective, orally active inhibitor of dihydroorotic dehydrogenase (DHODH) (IC50: 0.3 nM) and can be used in acute myeloid leukaemia (AML) studies. | |||
T63652 | DHODH-IN-19 | ||
DHODH-IN-19 is a potent inhibitor of DHODH. DHODH-IN-19 has shown research potential for cancer and inflammatory diseases. | |||
T62462 | RORγt/DHODH-IN-2 | ||
RORγt/DHODH-IN-2 (compound 1) is a potent dual RORγt/DHODH inhibitor that can be used in the study of inflammatory bowel disease (IBD). | |||
T64146 | RORγt/DHODH-IN-3 | ||
RORγt/DHODH-IN-3 (compound (S)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.098 μM) and DHODH (IC50: 0.432 μM).RORγt/DHODH-IN-1 has significant in vivo anti-inflammatory effects. | |||
T64145 | RORγt/DHODH-IN-1 | ||
RORγt/DHODH-IN-1 (compound (R)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.083 μM) and DHODH (IC50: 0.172 μM), which exhibits significant in vivo anti-inflammatory effects. | |||
T9394 | CHIKV-IN-2 | Dehydrogenase | |
CHIKV-IN-2, a chemical compound, exhibits potent inhibitory activity against the enzyme Dihydroorotate Dehydrogenase (DHODH), crucial for pyrimidine synthesis affecting various viruses' replication. It serves as an effec... | |||
T9121 | AG-636 | Dehydrogenase , DNA/RNA Synthesis | |
AG-636 is a potent, reversible, selective and orally active DHODH inhibitor(IC50 of 17 nM). It has strong anticancer effects. | |||
T8767 | PfDHODH-IN-2 | Dehydrogenase , Parasite | |
PfDHODH-IN-2 is a dihydrothiophenone derivative, is a potent Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH, IC50 : 1.11 μM) inhibitor . It is used an antimalarial agent and can be used for the research of m... | |||
T14501 | BAY-2402234 | Dehydrogenase , DNA/RNA Synthesis | |
BAY-2402234 is an inhibitor of dihydroorotate dehydrogenase (DHODH) for the treatment of myeloid malignancies.BAY 2402234 is a selective low-nanomolar inhibitor of human DHODH enzymatic activity. | |||
T2601 | Vidofludimus | SC12267,4sc-101 | Dehydrogenase , DNA/RNA Synthesis , Interleukin |
Vidofludimus (SC12267) (4SC-101, SC12267) is a novel small molecule inhibitor of dihydroorotate dehydrogenase (DHODH). | |||
T13774 | ML390 | Others , Dehydrogenase | |
ML390 exerts its potent differentiation effect on multiple leukemia models. | |||
T1818 | Tenovin-6 | Tenovin 6 | Dehydrogenase , Sirtuin , Autophagy |
Tenovin-6 is a p53 transcriptional activity agonist. | |||
T1919 | Tenovin-1 | Tenovin 1 | Mdm2 , Dehydrogenase , Sirtuin , p53 , Autophagy |
Tenovin-1 inhibits protein-deacetylating activities of SirT1 and SirT2 and protects against MDM2-mediated p53 degradation, which involves ubiquitination. | |||
T8480 | Tenovin-6 Hydrochloride | Dehydrogenase , Sirtuin , HDAC , p53 , Autophagy | |
Tenovin-6 Hydrochloride is an SIRT1, SIRT2 and HDAC8 inhibitor(IC50s of 21 μM, 10 μM, and 67 μM for SirT1, SirT2, and SirT3, respectively), and is also a potent p53 activator . | |||
T10384 | Farudodstat | ASLAN003 | Apoptosis , Dehydrogenase , DNA/RNA Synthesis |
Farudodstat (ASLAN003) is an orally active and potent inhibitor of DHODH (Human Dihydroorotate Dehydrogenase) with antitumor activity. It has the potential to be a first-in-class candidate in AML. | |||
T5013 | Brequinar | Bipenquinate,NSC 368390,DUP785 | Virus Protease , Dehydrogenase , DNA/RNA Synthesis |
Brequinar (NSC-368390) is a potent inhibitor of dihydroorotate dehydrogenase, with potent activities against a broad spectrum of viruses. | |||
T1159 | Leflunomide | SU101,RS-34821,HWA486 | Others , Dehydrogenase , AhR |
Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. | |||
T12574 | PTC299 | Emvododstat,(4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate | VEGFR , Dehydrogenase |
PTC299 ((4-chlorophenyl) (1S)-6-chloro-1-(4-methoxyphenyl)-1,3,4,9-tetrahydropyrido[3,4-b]indole-2-carboxylate) is an orally active inhibitor of VEGFA mRNA translation and selectively inhibits VEGF protein synthesis at t... | |||
T11546 | HDHODH-IN-1 | Dehydrogenase | |
hDHODH-IN-1 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor with an anti-inflammatory effect. | |||
T12438 | PfDHODH-IN-1 | Dehydrogenase , Parasite | |
PfDHODH-IN-1 is an analogue of the active Leflunomide metabolite, has antimalarial activity. | |||
T78932 | HDHODH-IN-12 | DNA/RNA Synthesis | |
hDHODH-IN-12 is a potent inhibitor of dihydroorotate dehydrogenase (DHODH), exhibiting an inhibitory concentration (IC50) of 0.421 μM. As the rate-limiting enzyme in the de novo synthesis of pyrimidines, critical for DNA... | |||
T72948 | HDHODH-IN-11 | ||
hDHODH-IN-11, a potent inhibitor of human dihydroorotate dehydrogenase (hDHODH), exhibits an IC50 value of 7.2 nM and has low cytotoxicity. It is applicable in acute myeloid leukemia (AML) research. | |||
T61226 | HDHODH-IN-9 | ||
hDHODH-IN-9 (Compound 3k) is a highly potent inhibitor of hDHODH, exhibiting an IC50 of 0.34 μM. It displays significant cytotoxic activity against MCF-7 and A375 cells, while maintaining good selectivity. With its chara... | |||
T64360 | HDHODH-IN-8 | Dehydrogenase | |
hDHODH-IN-8 is a potent inhibitor of human dihydroorotate dehydrogenase (hDHODH) with an IC50 of 16 nM. hDHODH-IN-8 has potent antiproliferative activity and excellent aqueous solubility. hDHODH-IN-8 has the potential fo... | |||
T63037 | HDHODH-IN-10 | ||
hDHODH-IN-10 is a selective, orally active, potent hDHODH inhibitor (IC50: 10.9 nM) that forms hydrogen bonds with key residues Arg136 and Gln47. hDHODH-IN-10 inhibits the proliferation of cancer cells and can be used to... | |||
T11547 | HDHODH-IN-2 | Others | |
hDHODH-IN-2 is an analogue of the active metabolite of Leflunomide. hDHODH-IN-2 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor with anti-inflammatory activity. | |||
T82223 | HDHODH-IN-13 | ||
hDHODH-IN-13 (compound w2), an inhibitor of human dihydroorotate dehydrogenase (hDHODH), exhibits an IC50 of 173.4 nM and has potential research applications in studying inflammatory bowel disease (IBD) [1]. | |||
T27300 | Olorofim | Olorofim,F901318,F-901318 | |
Olorofim is a novel selective antifungal compound with inhibitory effect on Aspergillus fumigatus DHODH (IC50: 44 nM) and almost no inhibitory effect on human DHODH (>100 uM).Olorofim has good efficacy against various pa... | |||
T8332 | Bipenquinate | Dehydrogenase | |
Bipenquinate is a potent and selective inhibitor of dihydroorotate dehydrogenase (DHODH) with IC50 of 20 nM, blocking de novo pyrimidine biosynthesis. | |||
T27214 | DSM421 | DSM 421,DSM-421 | Dehydrogenase |
DSM421 (DSM-421) is a dihydrodehydrogenase inhibitor (DHODH) that is in preclinical development as a potential treatment option for malaria and has shown activity against field isolates of both P. falciparum and P. vivax... | |||
T40087 | DSM502 | ||
DSM502, a pyrrole-based Dihydroorotate Dehydrogenase (DHODH) inhibitor, demonstrates potent nanomolar activity against Plasmodium DHODH and Plasmodium parasites, while not inhibiting mammalian DHODHs. |
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TN2373 | (E/Z)-Ginkgolic acid C17:2 | Ginkgolic Acid C17:2 | Dehydrogenase |
(E/Z)-Ginkgolic acid C17:2 (Ginkgolic Acid C17:2) is a natural product that can be extracted from Ginkgo biloba and targets human dihydroorotic acid dehydrogenase (DHODH). | |||
T0746 | Orotic acid | Vitamin B13,6-Carboxyuracil | Nucleoside Antimetabolite/Analog , Dehydrogenase , Endogenous Metabolite |
Orotic acid (Vitamin B13) is an intermediate product in pyrimidine metabolism. | |||
T3271 | Orotic acid zinc | Orotic acid zinc salt dihydrate,Zinc Orotate | Nucleoside Antimetabolite/Analog , Others , Endogenous Metabolite |
Orotic acid zinc (Zinc Orotate) salt dihydrate is an intermediate product in pyrimidine synthesis. |
Cat No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-01225 | DHODH Protein, Human, Recombinant (His) | Human | E. coli |
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. | |||
TMPH-02850 | DHODH Protein, Mouse, Recombinant (His) | Mouse | E. coli |
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. | |||
TMPH-03278 | DHODH Protein, Rat, Recombinant (His) | Rat | E. coli |
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. | |||
TMPH-02627 | DHODH Protein, Mouse, Recombinant (E. coli, His) | Mouse | E. coli |
Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. |